Amplia Therapeutics Ltd.ASX: ATX

Approval to Initiate Phase2 Pancreatic Cancer Trial in Korea

Dec 4, 2023 at 3:06 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment